Plant Comparison
Lingzhi vs Motherwort
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Lingzhi and Motherwort: they share 5 indicated uses (arthritis / joint pain, cardiovascular / heart health, inflammation (general), …); 3 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Lingzhi | Motherwort | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 1/10 | Comparable evidence |
| Cardiovascular / heart health | 1/10 | 2/10 | Comparable evidence |
| Inflammation (general) | 1/10 | 1/10 | Comparable evidence |
| Insomnia / sleeplessness | 1/10 | 2/10 | Comparable evidence |
| Skin irritation | 1/10 | 1/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Principal immunomodulatory constituents, the main focus of anticancer-adjunct and immune research.
Bitter triterpenes associated with anti-inflammatory, hepatoprotective and adaptogenic activity.
Leonurine and related iridoid/alkaloid-type constituents are considered the principal cardioactive and uterotonic compounds.
Antioxidant constituents contributing to the plant's anti-inflammatory activity.
Bitter diterpenes, shared with related Lamiaceae bitters, contributing to the traditional digestive and cardiac reputation.
Pharmacological Actions
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from anticancer action
inferred from antiviral action
inferred from anti-inflammatory action
inferred from sedative action
inferred from antidiabetic action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from sedative action
inferred from antispasmodic action
Safety, Cautions & Contraindications
Generally well tolerated at standard doses. May cause mild digestive upset, dry mouth, or dizziness in some individuals. May enhance the effects of anticoagulant and antihypertensive medications. Avoid during pregnancy and breastfeeding. Extended use beyond 6 months is not well studied in humans.
Duke (2002) rates reishi (Ganoderma lucidum) as + and notes immunostimulant, hepatoprotective, antioxidant, antitumor, and hypoglycemic activities at the experimental level (score 1). It is a key adaptogen in traditional Chinese medicine, valued for its polysaccharide (beta-glucan) content. Duke notes antiviral (score 1) and anti-aggregant activities. No strong clinical trials existed at time of publication, but lentinan and polysaccharide fractions from related species show immunomodulatory potential. Duke suggests caution in bleeding disorders due to anti-aggregant activity (Duke, 2002).
Contraindicated in pregnancy (uterine stimulant). Avoid in heavy menstrual bleeding. May enhance anticoagulant and antihypertensive drug effects. Avoid in thyroid disorders. Generally well tolerated in normal doses for short-term use.
Duke (2002) rates motherwort as ++ and notes hypotensive, cardiotonic (negative chronotropic), anti-aggregant, and sedative activities at the experimental level (score 1). The plant is traditionally used for heart palpitations, hypertension, and menstrual regulation in European herbalism. Duke emphasizes strong safety caution: motherwort has documented oxytocic (uterine-stimulating) activity and is strictly contraindicated in pregnancy. It may also enhance the effects of cardiac medications and sedatives (Duke, 2002).
External Ids
Botanical Description
Bracket (shelf) fungus (not a true plant) that grows on the trunks and stumps of deciduous trees. It develops a hard, kidney- or fan-shaped cap with a glossy, varnished, red-brown to mahogany crust and concentric growth rings, often on a lateral woody stalk; the pale underside is covered in fine pores that release rusty-brown spores. The mycelium spreads through the wood substrate before fruiting.[1]
Tall, upright perennial herb with deeply palmately lobed lower leaves (giving a lion's-paw appearance, the source of the genus name) and progressively less-divided upper leaves. Small, pink to pale purple, spiny-toothed, two-lipped flowers are borne in dense whorls up the square stem.[1]
Habitat
Grows as a wood-decay fungus on the stumps and trunks of deciduous trees (notably maple and other hardwoods) in East Asian forests; also widely cultivated commercially on hardwood logs or sawdust substrate.
Grows on waste ground, roadsides, hedgerows and near old dwellings; native to Central Asia and southeastern Europe and long naturalised across Europe and North America.[1]
Harvesting
Wild fruiting bodies are collected once mature; cultivated material is harvested from logs or substrate at maturity, then dried and processed into slices, powder or extract.
The flowering aerial parts (leaf, stem and flower) are cut in summer as the plant comes into flower, and dried in a warm, shaded, airy place.[1]
Traditional Uses
Reishi/lingzhi, the 'mushroom of immortality', is one of the most revered tonic fungi in traditional Chinese medicine, used for centuries to support vitality, calm the spirit, strengthen immunity and promote longevity; this traditional tonic reputation is now studied for immunomodulatory, anticancer-adjunct and metabolic effects.[1, 4]
Motherwort has a long European and Asian herbal tradition, reflected in its name, as a gynaecological and cardiac tonic, traditionally used for heart palpitations and nervous cardiac complaints, menstrual irregularities and cramps, and as a calming nervine for anxiety and to ease childbirth and postpartum recovery.[1, 6]
Preparations
References
Drug Class Interactions
Lookalikes Review
Dangerous Lookalikes
Not documented
Dosage
Not documented
The EU herbal monograph gives a single dose of 1.5-4.5 g of the comminuted herb for tea preparation, for a daily dose of 3-10 g, in adults and elderly; a 1:5 tincture in 45% V/V ethanol at 2-6 mL three times daily and a liquid extract at 2-4 mL three times daily are also listed. If symptoms persist longer than 4 weeks a healthcare practitioner should be consulted. Not recommended under 18 years. Educational reference only, not a prescription.
References & Sources
- Li, W., Zhou, Q., Lv, B., Li, N. et al (2024) 'Ganoderma lucidum Polysaccharide Supplementation Significantly Activates T-Cell-Mediated Antitumor Immunity and Enhances Anti-PD-1 Immunotherapy Efficacy in Colorectal Cancer', Journal of Agricultural and Food Chemistry, 72(21), pp. 12072-12082. doi:10.1021/acs.jafc.3c08385 Preclinical
https://doi.org/10.1021/acs.jafc.3c08385 - Cai, Q., Li, Y. and Pei, G (2017) 'Polysaccharides from Ganoderma lucidum attenuate microglia-mediated neuroinflammation and modulate microglial phagocytosis and behavioural response', Journal of Neuroinflammation, 14(1), pp. 63. doi:10.1186/s12974-017-0839-0 Preclinical
https://doi.org/10.1186/s12974-017-0839-0 - Zheng, G., Zhao, Y., Li, Z., Hua, Y. et al (2023) 'Ganoderma lucidum spore powder and derived triterpenes attenuate atherosclerosis and aortic calcification by stimulating ABCA1/G1-mediated macrophage cholesterol efflux and inactivating RUNX2-mediated VSMC osteogenesis', Theranostics, 13(4), pp. 1325-1341. doi:10.7150/thno.80250 Preclinical
https://doi.org/10.7150/thno.80250 - Sohretoglu, D. and Huang, S (2018) 'Ganoderma lucidum Polysaccharides as An Anti-cancer Agent', Anti-Cancer Agents in Medicinal Chemistry, 18(5), pp. 667-674. doi:10.2174/1871520617666171113121246 Meta-analysis / review
https://doi.org/10.2174/1871520617666171113121246 - Seweryn, E., Ziala, A. and Gamian, A (2021) 'Health-Promoting of Polysaccharides Extracted from Ganoderma lucidum', Nutrients, 13(8), pp. 2725. doi:10.3390/nu13082725 Meta-analysis / review
https://doi.org/10.3390/nu13082725 - Liu, X., Yang, L., Li, G., Jiang, Y., Zhang, G. and Ling, J (2022) 'A novel promising neuroprotective agent: Ganoderma lucidum polysaccharide', International Journal of Biological Macromolecules, 229, pp. 168-180. doi:10.1016/j.ijbiomac.2022.12.276 Meta-analysis / review
https://doi.org/10.1016/j.ijbiomac.2022.12.276 - Zhu, M., Chang, Q., Wong, L.K., Chong, F.S. and Li, R.C (1999) 'Triterpene antioxidants from Ganoderma lucidum', Phytotherapy Research, 13(6), pp. 529-531. doi:10.1002/(sici)1099-1573(199909)13:6<529::aid-ptr481>3.0.co;2-x Preclinical
https://doi.org/10.1002/(sici)1099-1573(199909)13:6<529::aid-ptr481>3.0.co;2-x - Zeng, P., Chen, Y., Zhang, L. and Xing, M (2019) 'Ganoderma lucidum polysaccharide used for treating physical frailty in China', Progress in Molecular Biology and Translational Science, 163, pp. 179-219. doi:10.1016/bs.pmbts.2019.02.009 Meta-analysis / review
https://doi.org/10.1016/bs.pmbts.2019.02.009 - Wu, P., Zhang, C., Yin, Y., Zhang, X., Li, Q., Yuan, L., Sun, Y., Zhou, S., Ying, S. and Wu, J (2024) 'Bioactivities and industrial standardization status of Ganoderma lucidum: A comprehensive review', Heliyon, 10(19), pp. e36987. doi:10.1016/j.heliyon.2024.e36987 Meta-analysis / review
https://doi.org/10.1016/j.heliyon.2024.e36987 - Xu, Z., Chen, X., Zhong, Z., Chen, L. and Wang, Y (2011) 'Ganoderma lucidum polysaccharides: immunomodulation and potential anti-tumor activities', The American Journal of Chinese Medicine, 39(1), pp. 15-27. doi:10.1142/S0192415X11008610 Meta-analysis / review
https://doi.org/10.1142/S0192415X11008610 - Geng, X., Zhong, D., Su, L., Lin, Z. and Yang, B (2019) 'Preventive and therapeutic effect of Ganoderma lucidum on kidney injuries and diseases', Advances in Pharmacology, 87, pp. 257-276. doi:10.1016/bs.apha.2019.10.003 Meta-analysis / review
https://doi.org/10.1016/bs.apha.2019.10.003 - Sliva, D (2004) 'Cellular and physiological effects of Ganoderma lucidum (Reishi)', Mini Reviews in Medicinal Chemistry, 4(8), pp. 873-879. doi:10.2174/1389557043403323 Meta-analysis / review
https://doi.org/10.2174/1389557043403323 - Boh, B., Berovic, M., Zhang, J. and Zhi-Bin, L (2007) 'Ganoderma lucidum and its pharmaceutically active compounds', Biotechnology Annual Review, 13, pp. 265-301. doi:10.1016/S1387-2656(07)13010-6 Meta-analysis / review
https://doi.org/10.1016/S1387-2656(07)13010-6 - Bao, X. et al (2001) 'Structural requirements for the immunological activities of polysaccharides from Ganoderma lucidum', 41(9), pp. 2603--2611. Traditional / reference
https://scholar.google.com/scholar?q=Structural%20requirements%20for%20the%20immunological%20activities%20of%20polysaccharides%20from%20Ganoderma%20lucidum - Jin, X. et al (2012) 'Ganoderma lucidum (Reishi mushroom) for cancer treatment'. Traditional / reference
https://scholar.google.com/scholar?q=Ganoderma%20lucidum%20%28Reishi%20mushroom%29%20for%20cancer%20treatment - Wachtel-Galor, S., Yuen, J., Buswell, J.A. and Benzie, I.F.F (2011) 'Ganoderma lucidum (Lingzhi or Reishi): A Medicinal Mushroom'. Traditional / reference
https://scholar.google.com/scholar?q=Ganoderma%20lucidum%20%28Lingzhi%20or%20Reishi%29%3A%20A%20Medicinal%20Mushroom - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Ghasemzadeh Rahbardar, M. and Hosseinzadeh, H (2024) 'Therapeutic potential of hypnotic herbal medicines: A comprehensive review', Phytotherapy Research, 38(6), pp. 3037-3059. doi:10.1002/ptr.8201 Meta-analysis / review
https://doi.org/10.1002/ptr.8201 - Block, K.I., Gyllenhaal, C. and Mead, M.N (2004) 'Safety and efficacy of herbal sedatives in cancer care', Integrative Cancer Therapies, 3(2), pp. 128-148. doi:10.1177/1534735404265003 Meta-analysis / review
https://doi.org/10.1177/1534735404265003 - Ahn, J.Y. and Seok, S.J. and Song, J.E. and Choi, J.H. and Han, S.H. and Choi, J.Y. and Kim, C.O. and Song, Y.G. and Kim, J.M (2013) 'Two cases of mushroom poisoning by Podostroma cornu-damae', Yonsei Medical Journal, 54(1), pp. 265-8. doi:10.3349/ymj.2013.54.1.265 Clinical study
https://doi.org/10.3349/ymj.2013.54.1.265 - Choe, S. and In, S. and Jeon, Y. and Choi, H. and Kim, S (2018) 'Identification of trichothecene-type mycotoxins in toxic mushroom Podostroma cornu-damae and biological specimens from a fatal case by LC-QTOF/MS', Forensic Science International, 291, pp. 234-244. doi:10.1016/j.forsciint.2018.08.043 Clinical study
https://doi.org/10.1016/j.forsciint.2018.08.043
- Fierascu, R.C., Fierascu, I., Ortan, A., Fierascu, I.C. and others (2019) 'Leonurus cardiaca L. as a Source of Bioactive Compounds: An Update of the European Medicines Agency Assessment Report (2010)', BioMed Research International, 2019, pp. 4303215. doi:10.1155/2019/4303215 Traditional / reference
https://doi.org/10.1155/2019/4303215 - Wojtyniak, K., Szymanski, M. and Matlawska, I (2013) 'Leonurus cardiaca L. (motherwort): a review of its phytochemistry and pharmacology', Phytotherapy Research, 27(8), pp. 1115-1120. doi:10.1002/ptr.4850 Traditional / reference
https://doi.org/10.1002/ptr.4850 - Kuchta, K., Volk, R.B. and Rauwald, H.W (2013) 'Stachydrine in Leonurus cardiaca, Leonurus japonicus, Leonotis leonurus: detection and quantification by instrumental HPTLC and 1H-qNMR analyses', Pharmazie, 68(7), pp. 534-540. Available at: https://pubmed.ncbi.nlm.nih.gov/23923634/ Preclinical
https://pubmed.ncbi.nlm.nih.gov/23923634/ - Kuchta, K., Volk, R.B. and Rauwald, H.W (2012) 'Leonurus japonicus, Leonurus cardiaca, Leonotis leonurus: a novel HPLC study on the occurrence and content of the pharmacologically active guanidino derivative leonurine', Pharmazie, 67(12), pp. 973-979. Available at: https://pubmed.ncbi.nlm.nih.gov/23346757/ Preclinical
https://pubmed.ncbi.nlm.nih.gov/23346757/ - Koshovyi, O., Raal, A., Kireyev, I., Tryshchuk, N. and others (2021) 'Phytochemical and Psychotropic Research of Motherwort (Leonurus cardiaca L.) Modified Dry Extracts', Plants (Basel), 10(2), pp. 230. doi:10.3390/plants10020230 Preclinical
https://doi.org/10.3390/plants10020230 - Angeloni, S., Spinozzi, E., Maggi, F., Sagratini, G. and others (2021) 'Phytochemical Profile and Biological Activities of Crude and Purified Leonurus cardiaca Extracts', Plants (Basel), 10(2), pp. 195. doi:10.3390/plants10020195 Preclinical
https://doi.org/10.3390/plants10020195 - Sadowska, B., Wieckowska-Szakiel, M., Paszkiewicz, M. and Rozalska, B (2019) 'Molecular Mechanisms of Leonurus cardiaca L. Extract Activity in Prevention of Staphylococcal Endocarditis - Study on in Vitro and ex Vivo Models', Molecules, 24(18), pp. 3318. doi:10.3390/molecules24183318 Preclinical
https://doi.org/10.3390/molecules24183318 - Kuchta, K., Hladikova, J., Thomsen, M., Nguyen, A.D. and others (2025) 'Phenolic and Iridoid Glycosides from Leonurus cardiaca L. and Their Effects on the alpha, delta, and gamma Subtypes of the PPAR System', Molecules, 30(2), pp. 419. doi:10.3390/molecules30020419 Preclinical
https://doi.org/10.3390/molecules30020419 - Pereira, O.R., Catarino, M.D., Afonso, A.F., Silva, A.M.S. and Cardoso, S.M (2019) 'Hepatoprotection of Leonurus cardiaca L., Leonurus japonicus Houtt. and Leonurus sibiricus L', Antioxidants (Basel), 8(8), pp. 267. doi:10.3390/antiox8080267 Preclinical
https://doi.org/10.3390/antiox8080267 - Kuchta, K., Ortwein, J. and Rauwald, H.W (2014) '1H-qNMR for direct quantification of stachydrine in Leonurus japonicus and L. cardiaca', Fitoterapia, 96, pp. 8-17. doi:10.1016/j.fitote.2014.03.023 Preclinical
https://doi.org/10.1016/j.fitote.2014.03.023 - European Medicines Agency (HMPC) (2010) 'Community herbal monograph on Leonurus cardiaca L., herba'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-leonurus-cardiaca-l-herba_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-leonurus-cardiaca-l-herba_en.pdf - Kowalchik, C. and Hylton, W (1998) 'Rodale'. Traditional / reference
https://scholar.google.com/scholar?q=Rodale - Prajapati, N.D., Purohit, S.S., Sharma, A.K. and Kumar, T (2003) 'A Handbook of Medicinal Plants'. Traditional / reference
https://scholar.google.com/scholar?q=A%20Handbook%20of%20Medicinal%20Plants - Shang, X. et al (2014) 'The genus Leonurus: traditional uses, phytochemistry and pharmacology', pp. 43--63. Traditional / reference
https://scholar.google.com/scholar?q=The%20genus%20Leonurus%3A%20traditional%20uses%2C%20phytochemistry%20and%20pharmacology - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Ghasemzadeh Rahbardar, M. and Hosseinzadeh, H (2024) 'Therapeutic potential of hypnotic herbal medicines: A comprehensive review', Phytotherapy Research, 38(6), pp. 3037-3059. doi:10.1002/ptr.8201 Meta-analysis / review
https://doi.org/10.1002/ptr.8201 - Block, K.I., Gyllenhaal, C. and Mead, M.N (2004) 'Safety and efficacy of herbal sedatives in cancer care', Integrative Cancer Therapies, 3(2), pp. 128-148. doi:10.1177/1534735404265003 Meta-analysis / review
https://doi.org/10.1177/1534735404265003
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.